T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference

Rhea-AI Summary

T2 Biosystems, a leader in rapid detection of sepsis-causing pathogens, announced participation in the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 3:00 PM ET. Interested individuals can access the live and recorded webcast on the Company’s website. T2 Biosystems is dedicated to enhancing patient care by enabling faster treatment options through its advanced diagnostic products, including the T2Dx® Instrument and various pathogen detection panels, all powered by proprietary T2 Magnetic Resonance technology.

LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference.

Management is scheduled to present Wednesday, August 11, 2021, at 3:00pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.

Media Contact:
Gina Kent, Vault Communications
gkent@vaultcommunications.com
610-455-2763

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

When is T2 Biosystems presenting at the Canaccord Genuity 41st Annual Growth Conference?

T2 Biosystems is scheduled to present on August 11, 2021, at 3:00 PM ET.

How can I watch T2 Biosystems' presentation at the conference?

You can access the live and recorded webcast of T2 Biosystems' presentation on the 'Investors' section of their website.

What products does T2 Biosystems offer for sepsis detection?

T2 Biosystems offers products like the T2Dx® Instrument, T2Candida® Panel, T2Bacteria® Panel, and T2Resistance™ Panel, among others.

What technology powers T2 Biosystems' diagnostic products?

T2 Biosystems' products are powered by proprietary T2 Magnetic Resonance (T2MR®) technology.

What is T2 Biosystems' focus in patient care?

T2 Biosystems aims to improve patient care and reduce costs by enabling faster and more effective treatment of infections.